Cargando…
Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
The oncoprotein transcription factor MYC is overexpressed in the majority of cancers. Key to its oncogenic activity is the ability of MYC to regulate gene expression patterns that drive and maintain the malignant state. MYC is also considered a validated anticancer target, but efforts to pharmacolog...
Autores principales: | Thomas, Lance R., Adams, Clare M., Wang, Jing, Weissmiller, April M., Creighton, Joy, Lorey, Shelly L., Liu, Qi, Fesik, Stephen W., Eischen, Christine M., Tansey, William P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911241/ https://www.ncbi.nlm.nih.gov/pubmed/31767764 http://dx.doi.org/10.1073/pnas.1910391116 |
Ejemplares similares
-
Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020) -
WIN site inhibition disrupts a subset of WDR5 function
por: Siladi, Andrew J., et al.
Publicado: (2022) -
Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler
por: Woodley, Chase M., et al.
Publicado: (2021) -
Targeting WDR5: A WINning Anti-Cancer Strategy?
por: Aho, Erin R, et al.
Publicado: (2019) -
Biosynthesis of the nitrogenase active-site cofactor precursor NifB-co in Saccharomyces cerevisiae
por: Burén, Stefan, et al.
Publicado: (2019)